|Date||Analyst Firm||Analyst Name||Action||Rating||Action Price||Prior Price||Target|
|Ticker||Company||Price||Change||Chg %||Mkt Cap|
You can purchase shares of XTL Biopharmaceuticals (NASDAQ: XTLB) through any online brokerage.
There are no as such competitors for XTL Biopharmaceuticals.
The latest price target for XTL Biopharmaceuticals (NASDAQ: XTLB) was reported by H.C. Wainwright on 2015-05-08. The analyst firm set a price target for 6.00 expecting XTLB to rise to within 12 months (a possible 87.50% upside). 0 analyst firms have reported ratings in the last year.
The stock price for XTL Biopharmaceuticals (NASDAQ: XTLB) is $3.2 last updated Today at 8:00:02 PM.
There are no upcoming dividends for XTL Biopharmaceuticals.
There are no earnings for XTL Biopharmaceuticals
There is no upcoming split for XTL Biopharmaceuticals.